Impact of TIPS on muscle mass and outcomes in cirrhosis patients
Official title: Single-center Randomized Controlled Trial to Evaluate Body Composition Changes and Clinical Outcomes After Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation in Patients With Cirrhosis and Complications of Portal Hypertension Awaiting Liver Transplantation
Run by Oregon Health and Science University · NCT05420753 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing whether getting a TIPS procedure helps people with cirrhosis gain muscle mass and improve their physical function while they wait for a liver transplant.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 22 (estimated) |
| Sponsor | Oregon Health and Science University Academic / other |
| Locations | 1 site (Portland, Oregon) |
| Trial ID | NCT05420753 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 99 with cirrhosis who are on the liver transplant waiting list and have complications related to portal hypertension.
✕Probably not a fit
Patients with active malignancies, uncontrolled coagulopathy, or those requiring emergency TIPS creation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to prospectively evaluate how the creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS) affects muscle mass and physical function in patients with cirrhosis awaiting liver transplantation. It will compare patients undergoing TIPS with those who are not, tracking changes in body composition and muscle function over the first 12 months post-procedure. The goal is to determine if improvements in muscle mass correlate with better clinical outcomes in this population, building on previous observational findings.
Why it matters
Potential benefit: If successful, this study could lead to improved muscle mass and better clinical outcomes for patients with cirrhosis awaiting liver transplantation.
How similar studies have gone: Previous observational studies have indicated positive outcomes with similar approaches, but this study represents a novel prospective evaluation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients \>18 \<99 with cirrhosis wait listed for liver transplantation * Evidence of complications of portal hypertension: * Ascites or hydrothorax requiring escalation of diuretic medication * Persistent ascites or hydrothorax despite diuretic use, or intolerance of diuretic use * Gastrointestinal varices and blood loss anemia or history of variceal hemorrhage * Portal hypertensive gastropathy and blood loss anemia * Chronic portal vein thrombosis requiring recanalization and TIPS for transplant Exclusion Criteria: * Hepatocellular carcinoma or other active malignancy * Recurrent overt hepatic encephalopathy * Uncontrolled coagulopathy with maximum amplitude (MA) \<30 on thromboelastography * Bacteremia or sepsis * MELD \> 25 * Pregnant * Decisionally impaired individuals * Need for emergency TIPS creation * Patients who do not have acceptable alternatives to TIPS creation to manage their disease
Where it's running
-
Oregon Health and Science University
Portland, Oregon, United States Recruiting
Study contacts
- Study coordinator: Khashayar Farsad, MD
- Email: farsad@ohsu.edu
- Phone: 503-494-7660
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-protein, plant-dominant diet for people with liver cirrhosis
This 6-month test compares a high-protein, mostly plant-based diet to a usual low-fat animal-protein diet in adults with decompensated cirrhosis who are awaiting kidney transplant to see which better preserves nutrition and muscle.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
-
GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes
This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.
-
Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis
We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.